Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
8.84 USD 1.20 ( 15.71%)
Last update at 2026-11-11T21:00:00Z
VOLUME
223585
Market Cap
25.59M

Momentum Score

…

Axe Compute Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies. It operates through two segments, Pittsburgh and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of 150,000+ tumor samples. This segment also creates proprietary 3D culture models used in drug development. Its Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. Predictive Oncology Inc. has a strategic collaboration with Every Cure to identify and prioritize drugs for repurposing. The company was formerly known as Predictive Oncology Inc. and changed its name to Axe Compute Inc. in December 2025. Axe Compute Inc. was incorporated in 2002 and is headquartered in Pittsburgh, Pennsylvania.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
7.92
Low
8.90
High
52 Week Price Range
1.03
Low
32.10
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public information on Axe Compute Inc. (AGPU.US) is limited; filings do not provide a clear, verifiable description of the company's core products, customers or financial track record. Consequently long‑term growth drivers are undocumented and investors should consult SEC filings and company reports. The equity may appeal only to those prepared to monitor disclosure, revenue progress and execution closely.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
7.64
Dividend Yield
-
Revenue TTM
0.13M
Revenue Per Share
0.01
Gross Profit TTM
0.05M
Debt / Equity
0.03
ROE
-980.14%
Net Debt
-9.12M
ROCE
-58.46%
Diluted EPS TTM
-13.36

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -232.85M -10.86M -12.02M -25.74M -20.32M
Net income -233.10M -12.20M -13.98M -25.74M -19.66M
Selling general administrative 25.92M 7.42M 7.57M 11.11M 10.93M
Selling and marketing expenses 0.41M 1.47M 1.49M 1.36M 0.77M
Gross profit 0.05M 0.80M 1.02M 1.00M 0.93M
Reconciled depreciation 0.69M 0.70M 0.72M 1.31M 1.34M
Ebit -28.43M -10.94M -12.12M -15.27M -13.47M
Ebitda -27.74M -10.24M -11.87M -13.95M -12.13M
Depreciation and amortization 0.69M 0.70M 0.24M 1.31M 1.34M
Operating income -28.43M -10.94M -12.12M -26.03M -20.43M
Other operating expenses 28.55M 12.56M 13.75M 27.54M 21.85M
Interest expense - - - 10.65M -
Tax provision - - - 0.00M -0.66M
Income tax expense - - - - -0.66M
Total revenue 0.13M 1.62M 1.63M 1.51M 1.42M
Total operating expenses 28.48M 11.74M 13.14M 27.03M 21.36M
Cost of revenue 0.07M 0.83M 0.61M 0.51M 0.49M
Total other income expense net -204.43M 0.08M 0.10M 0.30M 0.11M
Net income from continuing ops -232.85M -10.86M -12.02M -25.74M -19.66M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 52.89M 4.97M 14.42M 25.73M 43.77M
Intangible assets - 0.21M 0.25M 0.25M 3.96M
Other current assets 31.95M 0.36M 0.59M 0.53M 0.51M
Total liab 5.17M 5.18M 6.15M 3.97M 3.51M
Total stockholder equity 47.72M -0.20M 8.27M 21.77M 40.27M
Other current liab 1.66M 1.57M 1.72M 2.24M 1.39M
Common stock 0.04M 0.07M 0.04M 0.04M 0.66M
Capital stock 0.04M 0.07M 0.04M 0.04M 0.66M
Retained earnings -413.52M -180.43M -167.76M -153.78M -128.04M
Good will - - - 0.00M 6.86M
Other assets - - - - 0.00M
Cash 10.79M 0.73M 8.73M 22.07M 28.20M
Total current liabilities 4.27M 3.59M 3.95M 3.88M 3.24M
Current deferred revenue - 0.30M 0.30M 0.60M 0.19M
Net debt -9.12M 1.40M -6.00M -21.89M -27.32M
Short term debt 0.76M 0.57M 0.60M 0.09M 0.64M
Short long term debt 0.11M - 0.15M - -
Short long term debt total 1.67M 2.13M 2.73M 0.18M 0.88M
Other stockholder equity 461.20M 180.16M 175.99M 175.50M 167.65M
Total current assets 42.77M 2.23M 10.08M 23.36M 29.46M
Net receivables 0.03M 0.75M 0.28M 0.33M 0.35M
Inventory - 0.39M 0.48M 0.43M 0.39M
Accounts payable 1.84M 1.14M 1.33M 0.94M 1.02M
Non currrent assets other 8.41M 0.10M 0.12M 0.08M 0.17M
Non current assets total 10.12M 2.75M 4.34M 2.37M 14.31M
Capital lease obligations 1.56M 2.13M 2.58M 0.18M 0.88M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total cashflows from investing activities -31.99M 0.02M -0.30M -0.48M -10.61M
Net borrowings 0.11M -0.15M 0.15M 0.00M -4.16M
Total cash from financing activities 52.01M 3.94M 0.15M 6.72M 50.34M
Net income -233.10M -10.86M -12.02M -25.74M -19.66M
Change in cash 10.06M -7.99M -13.34M -6.13M 27.52M
Begin period cash flow 0.73M 8.73M 22.07M 28.20M 0.68M
End period cash flow 10.79M 0.73M 8.73M 22.07M 28.20M
Total cash from operating activities -9.96M -11.96M -13.19M -12.37M -12.21M
Issuance of capital stock 56.01M 4.96M 0.00M 6.74M 51.20M
Depreciation 0.69M 0.70M 0.72M 1.31M 1.34M
Other cashflows from investing activities -62.35M 0.03M -0.25M - -0.06M
Dividends paid - - 0.00M - -
Change to inventory - 0.10M -0.07M -0.04M -0.10M
Change to account receivables 0.00M -0.47M 0.02M 0.02M -0.02M
Sale purchase of stock - 0.00M -0.00M -0.03M -0.01M
Other cashflows from financing activities -4.11M - 0.00M - 4.39M
Capital expenditures 32.62M 0.01M 0.02M 0.48M 0.96M
Change in working capital 1.16M -0.91M -0.78M 0.87M -1.19M
Stock based compensation - - - 0.52M 0.92M
Other non cash items 221.29M -0.88M -1.12M 11.19M 7.04M
Free cash flow -42.49M -11.97M -13.21M -12.85M -13.17M

Peer Comparison*

Sector: Technology Industry: Software - Infrastructure

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
AGPU
Axe Compute Inc.
1.20
15.71%
8.84 - - 204.27 0.54 131.44 -0.51
MSFT
Microsoft Corporation
-12.04
2.26%
521.12 37.32 29.94 13.03 12.45 13.06 24.59
ORCL
Oracle Corporation
10.40
8.82%
128.38 21.96 17.89 5.91 7.08 7.82 14.89
CRWD
Crowdstrike Holdings Inc
3.30
1.46%
229.06 4849.80 188.68 46.01 47.24 43.89 559.34
FTNT
Fortinet Inc
4.55
3.68%
128.12 60.27 43.86 16.80 80.50 16.11 43.33

Profile*

Axe Compute Inc.

Axe Compute Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies. It operates through two segments, Pittsburgh and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of 150,000+ tumor samples. This segment also creates proprietary 3D culture models used in drug development. Its Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. Predictive Oncology Inc. has a strategic collaboration with Every Cure to identify and prioritize drugs for repurposing. The company was formerly known as Predictive Oncology Inc. and changed its name to Axe Compute Inc. in December 2025. Axe Compute Inc. was incorporated in 2002 and is headquartered in Pittsburgh, Pennsylvania.

91 43rd Street, Pittsburgh, PA, United States, 15201

412 432 1500

13

Name Title Year Born
Mr. Christopher Miglino CEO & Director 1969
Mr. Kyle Okamoto President NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…